These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3024599)

  • 1. Influence of dihydrolysergic acid amide on serotonergic and alpha-adrenergic receptors in human blood platelets and femoral veins in vitro.
    Glusa E; Markwardt F
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):303-11. PubMed ID: 3024599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
    Glusa E; Markwardt F
    Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.
    Kaywin P; McDonough M; Insel PA; Shattil SJ
    N Engl J Med; 1978 Sep; 299(10):505-9. PubMed ID: 210377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between amitraz and alpha 2-adrenoceptors inhibits epinephrine-induced canine platelet aggregation.
    Koeiman NR; Hsu WH
    Arch Int Pharmacodyn Ther; 1991; 310():56-65. PubMed ID: 1663333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML; Parli CJ; Fuller RW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R; Schäfer U; Ott T
    Arzneimittelforschung; 1992 Oct; 42(10):1175-9. PubMed ID: 1472137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E
    Z Gesamte Inn Med; 1984 Sep; 39(17):414-7. PubMed ID: 6095548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ergoline derivatives on platelet and blood vessels].
    Glusa E; Barthel W; Frosch G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):705-13. PubMed ID: 94864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.
    Hara H; Osakabe M; Kitajima A; Tamao Y; Kikumoto R
    Thromb Haemost; 1991 Apr; 65(4):415-20. PubMed ID: 2057925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES; Addonizio VP; Shattil SJ
    Am J Physiol; 1982 Jan; 242(1):H19-23. PubMed ID: 6277203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of lisuride with monoamine receptors on human blood platelets.
    Glusa E; Markwardt F
    Biochem Pharmacol; 1984 Feb; 33(3):493-6. PubMed ID: 6704167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.